The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate
Abstract
Mood stabilizing drugs lithium and valproate are the most commonly used treatments for bipolar disorder. Previous studies in our laboratory indicate that chronic treatment with lithium and valproate inhibits oxidative damage in primary cultured rat cerebral cortical cells. Glutathione, as the major antioxidant in the brain, plays a key role in defending against oxidative damage. The purpose of this study was to determine the role of glutathione in the neuroprotective effects of lithium and valproate against oxidative damage. We found that chronic treatment with lithium and valproate inhibited reactive oxygen metabolite H(2)O(2)-induced cell death in primary cultured rat cerebral cortical cells, while buthionine sulfoximine, an inhibitor of glutathione rate-limiting synthesis enzyme glutamate-cysteine ligase, reduced the neuroprotective effect of lithium and valproate against H(2)O(2)-induced cell death. Further, we found that chronic treatment with lithium and valproate increased glutathione levels in primary cultured rat cerebral cortical cells and that the effects of lithium and valproate on glutathione levels were dose-dependent in human neuroblastoma SH-SY5Y cells. Chronic treatment with lithium and valproate also increased the expression of glutamate-cysteine ligase in both rat cerebral cortical cells and SH-SY5Y cells. In addition, chronic treatment with other mood stabilizing drugs lamotrigine and carbamazepine, but not antidepressants desipramine and fluoxetine, increased both glutathione levels and the expression of glutamate-cysteine ligase in SH-SY5Y cells. These results suggest that glutathione plays an important role in the neuroprotective effects of lithium and valproate, and that glutathione may be a common target for mood stabilizing drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, consistent evidences are showing that the inhibition of oxidative damaging processes provoked by injuries to rat cerebral cortical cells by the chronic treatment with lithium is remarkably efficient [259].”
From Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches (2016) · cites this paper as [259]
Citations
Cites
Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Mitochondrial diseases in man and mouse
Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Örd, T., & Bredesen, D. E. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Biologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,210
Glutathione S-Transferase Polymorphisms and Their Biological Consequences
Hayes, J. D., & Strange, R. C. (2000) · Pharmacology · doi:10.1159/000028396 · Cited by 997
Frontal lobe and cognitive development
Fuster, J. M. (2002) · Journal of Neurocytology · doi:10.1023/a:1024190429920 · Cited by 916
Glutathione Pathways in the Brain
Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597
Textbook of psychopharmacology
Edwards, G. (1975) · Nature · doi:10.1038/258648b0 · Cited by 583
Rajkowska, G., Halaris, A. E., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 572
Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
Konradi, C. L., Eaton, M. E., MacDonald, M. L., Walsh, J. P., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 503
Chen, G., Zeng, W., YUAN, P., Huang, L., Jiang, Y., Zhao, Z., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720879.x · Cited by 490
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R., & Chuang, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 466
Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder
Dager, S. R., Friedman, S. D., Parow, A. M., Demopulos, C. M., Stoll, A. L., Lyoo, I. K., Dünner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 450
Yu, Z., Luo, H., Fu, W., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7002 · Cited by 438
Nonaka, S., Hough, C. J., & Chuang, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 428
Suicidal Behaviour in Bipolar Disorder
Tondo, L., Isacsson, G., & Baldessarini, R. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317070-00003 · Cited by 405
The functional neuroanatomy of mood disorders
Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379
Liu, H., Bowes, R. C., van de Water, B., Sillence, C., Nagelkerke, J. F., & Stevens, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21751 · Cited by 373
Drevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352
Sharma, R., Yang, Y., Sharma, A., Awasthi, S., & Awasthi, S. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604322899350 · Cited by 326
Hashimoto, R., Takei, N., Shimazu, K., Christ, L. A., Lu, B., & Chuang, D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00217-4 · Cited by 257
The Enzymes of Glutathione Synthesis: γ‐Glutamylcysteine Synthetase
Griffith, O. W., & Mulcahy, R. (1999) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123195.ch7 · Cited by 254
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
Nonaka, S., & Chuang, D. (1998) · Neuroreport · doi:10.1097/00001756-199806220-00031 · Cited by 250
Regulation of glutathione synthesis
Lu, S. C.-L. (2001) · Current topics in cellular regulation · doi:10.1016/s0070-2137(01)80004-2 · Cited by 240
Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0637 · Cited by 238
Sun, X., Wang, J., Tseng, M., & Young, L. T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0623 · Cited by 238
Self-citationKato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90097-4 · Cited by 227
Shao, L., Young, L. T., & Wang, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.052 · Cited by 218
Self-citationTextbook of Psychopharmacology
(1995) · Nature Medicine · doi:10.1038/nm0895-834 · Cited by 178
Kowaltowski, A. J., Vercesi, A. E., & Fiskum, G. M. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400722 · Cited by 159
HAMAKAWA, H., Murashita, J., Yamada, N., Inubushi, T., Kato, N., & Kato, T. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01197.x · Cited by 137
Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin
Skaper, S. D., Floreani, M., Ceccon, M., Facci, L., & Giusti, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07985.x · Cited by 135
Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder
Kato, T., Stine, O. C., McMahon, F. J., & Crowe, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00012-7 · Cited by 124
Cytoprotection by lithium and valproate varies between cell types and cellular stresses
Lai, J. S., Zhao, C., Warsh, J. J., & Li, P. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.076 · Cited by 122
Cortical Influences in Emotion
Heilman, K. M., & Gilmore, R. L. (1998) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199809000-00005 · Cited by 120
Decreased temporal lobe phosphomonoesters in bipolar disorder
Deicken, R. F., Weiner, M. W., & Fein, G. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00089-r · Cited by 119
Wang, J., Azzam, J. E., & Young, L. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00655-3 · Cited by 107
Self-citationThe nature of bipolar disorder.
Manji, H. K., & Lenox, R. H. (2000) · PubMed · Cited by 104
Wang, J., Bown, C. D., & Young, L. T. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12177-3 · Cited by 96
Self-citationShao, L., Sun, X., Xu, L., Young, L. T., & Wang, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.007 · Cited by 85
Self-citationGlutathione S‐transferase is a novel target for mood stabilizing drugs in primary cultured neurons
Wang, J., Shao, L., Sun, X., & Young, L. T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02276.x · Cited by 76
Self-citationChen, B., Wang, J. F., & Young, L. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00878-7 · Cited by 68
Self-citationKing, T. D., & Jope, R. S. (2005) · Neuroreport · doi:10.1097/00001756-200504250-00016 · Cited by 66
Vergauwen, B., Vos, D. E. D., & BEEUMEN, J. J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509517200 · Cited by 64
Cytoprotective effect is one of common action pathways for antidepressants.
Li, Y., Liu, Y., Huang, W.-C., & Luo, Z.-P. (2003) · PubMed · Cited by 59
Oxidative signaling and glutathione synthesis
Forman, H. J., & Dickinson, D. A. (2003) · BioFactors · doi:10.1002/biof.5520170101 · Cited by 56
Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells
Chen, B., Wang, J.-F., Sun, X., & Young, L. T. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01551-2 · Cited by 50
Self-citationWang, J., Asghari, V., Rockel, C. P., & Young, L. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00627-7 · Cited by 46
Self-citationBown, C. D., Wang, J., & Young, L. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00743-1 · Cited by 37
Self-citationWang, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00385-2 · Cited by 36
Self-citationDong, G.-X., Singh, D. K., Dendle, P., & Prasad, R. M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02379-4 · Cited by 18
Desipramine antagonized corticosterone-induced apoptosis in cultured PC12 cells.
Li, Y.-F., & Luo, Z.-P. (2002) · PubMed · Cited by 15
Cited by
Sorted by citations
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
Self-citationImpaired mitochondrial function in psychiatric disorders
Manji, H. K., Kato, T., Prospero, N. A. D., Ness, S. L., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3229 · Cited by 493
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & STRECK, E. L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 453
Metadata
- Authors
- Cui, J., Shao, L., Young, L. T., & Wang, J.-F.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Wang, J.-F.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 144
- Issue
- 4
- Pages
- 1447-1453
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2085156996
- Cited by
- 160
- References
- 54
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 9 · 2012: 20
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- glutathione, neuroprotection, mood stabilizers, lithium, valproic acid, bipolar disorder, oxidative stress, gamma-glutamylcysteine synthetase, buthionine sulfoximine, hydrogen peroxide-induced cell death, SH-SY5Y cells, lamotrigine, carbamazepine, glutathione synthesis
- MeSH terms
- Lamotrigine, Animals, Brain, Carbamazepine, Cells, Cultured, Cerebral Cortex, Enzyme Inhibitors, Glutamate-Cysteine Ligase, Glutathione, Humans, Lithium, Nerve Degeneration, Neurons, Triazines, Valproic Acid, Cell Death, Rats, Sprague-Dawley, Reactive Oxygen Species, Oxidative Stress, Antimanic Agents, Neuroprotective Agents, Cell Line, Tumor, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review